Conserved Interferon-γ Signaling Drives Clinical Response to Immune Checkpoint Blockade Therapy in MelanomaCatherine S. Grasso, Antoni Ribas, Mykola Onyshchenko et al.|Cancer Cell|2020Cited by 379
Antitumor Immune Responses in <i>B2M</i> -Deficient CancersDavis Y. Torrejon, Antoni Ribas|Cancer Immunology Research|2023Cited by 36